Company Filing History:
Years Active: 2002-2007
Title: Scott S Ganser: Innovator in Nitric Oxide Synthase Inhibitors
Introduction
Scott S Ganser is a notable inventor based in Chicago, IL, who has made significant contributions to the field of medicinal chemistry. With a total of five patents to his name, Ganser has focused his research on compounds that have therapeutic applications, particularly in the area of nitric oxide synthase inhibition.
Latest Patents
Ganser's latest patents include innovative amidino compounds that are useful as nitric oxide synthase inhibitors. The first patent describes amidino compounds and their salts and prodrugs, emphasizing their therapeutic potential. In another embodiment, he outlines methods for synthesizing these amidino compounds, specifically detailing a process for creating an alpha-amino acid compound through hydrolyzing conditions applied to a hydantoin compound.
Career Highlights
Throughout his career, Scott S Ganser has been associated with Pharmacia Corporation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and application of nitric oxide synthase inhibitors in therapeutic settings.
Collaborations
Ganser has collaborated with notable colleagues, including Ronald Keith Webber and Richard C Durley, enhancing the scope and impact of his research through teamwork and shared expertise.
Conclusion
Scott S Ganser's innovative work in the development of nitric oxide synthase inhibitors showcases his dedication to advancing medical science. His contributions through patents and collaborations reflect a commitment to improving therapeutic options in healthcare.